This invention relates to diaminopyrroloquinazoline compounds which are useful for inhibiting protein tyrosine phosphatases, particularly PTP1B, and are useful for lowering blood glucose concentrations in mammals.
这项发明涉及二
氨基
吡咯喹唑啉化合物,这些化合物对抑制蛋白
酪氨酸磷酸酶特别是
PTP1B具有用处,并且对降低哺乳动物的血糖浓度有用。